𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

✍ Scribed by David J. Park; Jan Stoehlmacher; Wu Zhang; Denice Tsao-Wei; Susan Groshen; Heinz-Josef Lenz


Book ID
106060654
Publisher
Springer
Year
2001
Tongue
English
Weight
35 KB
Volume
17
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Single nucleotide polymorphism in the 5β€²
✍ Eugenio Marcuello; Albert AltΓ©s; Elisabeth del Rio; Angeles CΓ©sar; Anna Menoyo; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 1 views

## Abstract Thymidylate synthase (TS) is the primary target of 5‐fluorouracil (5‐FU). A VNTR polymorphism in the TS promoter region is associated with the efficacy of 5‐FU‐based chemotherapy in colorectal cancer. A common G>C SNP at the 12th nucleotide of the second repeat in the TS\*3 alleles has

Predictive value of thymidylate synthase
✍ Li-Xin Qiu; Qi-Yun Tang; Jian-Ling Bai; Xiao-Ping Qian; Ru-Tian Li; Bao-Rui Liu; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 249 KB

## Abstract The published data about thymidylate synthase (TS) expression and its predictive value in advanced colorectal cancer (CRC) patients receiving fluoropyrimidine‐based chemotherapy seemed inconclusive. To derive a more precise estimation of the relationship, a metaanalysis was performed. S